AFLAC INC vs MOLINA HEALTHCARE, INC., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
25.6 against 0.42 is the pair in two numbers: net margin, supplemental insurance against Medicaid managed care, sixty times the profitability per revenue dollar. Aflac sells cancer and accident policies where pricing is actuarial and claims are bounded; Molina administers government health programs where margins are set in Sacramento and Washington. Molina has no meaningful multiple this year; Aflac trades at 13.7 times with a 2% dividend. Returns on equity run 15.5% against 4.6%. The two share a sector tag and a customer anxiety, medical costs, and nothing else; the page mostly documents how differently insurance can pay depending on who writes the rules.
Comparison updated 2026-07-10.
| Metric | AFL | MOH |
|---|---|---|
| Price | $120.07 | $229.88 |
| Market cap | $61.8B | $11.7B |
| Sector | Managed Care | Managed Care |
| Stage | Mature | Mature |
| P/E | 13.7 | — |
| P/B | 2.06 | 2.87 |
| P/S | 3.41 | 0.26 |
| EV/EBITDA | — | 16.5 |
| Revenue growth | +14.9% | +8.0% |
| Operating margin | — | 0.8% |
| Net margin | 25.6% | 0.4% |
| Return on equity | 15.5% | 4.6% |
| Return on assets | 4.0% | 1.1% |
| Return on invested capital | — | 2.6% |
| FCF yield | 4.8% | 2.1% |
| Dividend yield | 2.0% | — |
| Debt / equity | 0.26 | 0.92 |
| Current ratio | — | 1.63 |
| Altman Z (solvency) | 1.26 | 4.02 |
| Piotroski F (quality) | 7 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.